Abstract Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disease in
which many processes are detected including (neuro) inflammation. Many drugs have been …

Amyotrophic lateral sclerosis (ALS) is a severe neurodegenerative disease that is defined by
loss of upper and lower motor neurons, associated with accumulation of protein aggregates …

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease which leads
to death in a median time of 2–3 years. Inflammation has been claimed important to the ALS …

Neuroinflammation plays an important role in amyotrophic lateral sclerosis (ALS)
pathogenesis. However, it is difficult to evaluate inflammation of the central nervous system …

Interleukin-6 (IL-6) is a versatile cytokine crucial for immune response modulation,
inflammation regulation, and various physiological processes in the body. Its wide-ranging …

Amyotrophic lateral sclerosis (ALS) is a fatal disease characterized by the degeneration and
death of motor neurons. Systemic neuroinflammation contributes to the pathogenesis of …

The main reason for short survival in amyotrophic lateral sclerosis (ALS) is involvement of
respiratory muscles. Severe compromise of diaphragmatic function due to marked loss of …

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by
progressive motor neuron damage. Due to the complexity of the ALS, so far the etiology and …

Biomarkers in amyotrophic lateral sclerosis: a review of new... : Current Opinion in
Neurology Biomarkers in amyotrophic lateral sclerosis: a review of new developments …

Objectives: In the present study, inflammatory factors, including interleukin (IL) and tumor
necrosis factor-α (TNF-α) in the peripheral blood of patients with sporadic amyotrophic …